Elevation Oncology (ELEV US)

Analysis

Health Care • United States

Elevation Oncology, Inc. operates as a biotechnology company. The Company focuses on the identification and targeted inhibition of tumor's specific drive alteration. Elevation Oncology serves patients in the United States.

Refresh

Focused

No publications yet

Add Elevation Oncology to your Watchlist to get alerts on new publications

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00